this post was submitted on 27 Oct 2023
9 points (100.0% liked)

Public Health

1055 readers
2 users here now

For issues concerning:


๐Ÿฉบ This community has a broader scope so please feel free to discuss. When it may not be clear, leave a comment talking about why something is important.



Related Communities

See the pinned post in the Medical Community Hub for links and descriptions. link ([email protected])


Rules

Given the inherent intersection that these topics have with politics, we encourage thoughtful discussions while also adhering to the mander.xyz instance guidelines.

Try to focus on the scientific aspects and refrain from making overly partisan or inflammatory content

Our aim is to foster a respectful environment where we can delve into the scientific foundations of these topics. Thank you!

founded 2 years ago
MODERATORS
top 1 comments
sorted by: hot top controversial new old
[โ€“] [email protected] 2 points 2 years ago

A virus invades the body and the immune system begins to work: Antibodies develop that fight the infection. At the same time, an immune memory builds up so that antibodies can be quickly made available in the event of a new infection. Surprisingly, antibodies can also form against polyethylene glycol (PEG), a molecule with a fairly simple structure.

In addition to cosmetic products - from creams, perfumes and lotions to lipstick - polyethylene glycol is also used in medicine. Here, it serves as a kind of camouflage coat against the body's own immune system, thus increasing the circulation time of an active ingredient in the blood.

"For us, PEG is interesting for coating nano-sized drug carriers with it," says Svenja Morsbach, group leader in Katharina Landfester's department at the MPI for Polymer Research. In this way, the researchers achieve a longer circulation time for the drug capsules, which are only nanometers in size and could be an important component in novel cancer therapies in the future, for example.

In their studies, the team led by Morsbach and Landfester examined more than 500 blood samples from patients taken in 2019. "The antibodies formed against PEG attach themselves to the coated nanocarriers, thus counteracting the effect that is actually desired: the nanocarrier becomes visible to the immune system and is removed before it can exert its effect," explains Katharina Landfester, director of the department.

Very interesting! I wonder what they will replace PEG with.